|
C9ORF129 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.48629999979977E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23509999952576E-07 |
| Normal-vs-Stage2 |
3.480200E-02 |
| Normal-vs-Stage3 |
1.244150E-02 |
| Normal-vs-Stage4 |
3.997600E-02 |
| Stage1-vs-Stage2 |
4.146000E-01 |
| Stage1-vs-Stage3 |
3.724200E-01 |
| Stage1-vs-Stage4 |
8.022000E-01 |
| Stage2-vs-Stage3 |
9.735800E-01 |
| Stage2-vs-Stage4 |
4.897800E-01 |
| Stage3-vs-Stage4 |
4.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20119999952517E-07 |
| Normal-vs-AfricanAmerican |
6.5311999997153E-07 |
| Normal-vs-Asian |
6.237400E-04 |
| Caucasian-vs-AfricanAmerican |
5.421400E-01 |
| Caucasian-vs-Asian |
4.628200E-01 |
| AfricanAmerican-vs-Asian |
5.422800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.21800002995354E-09 |
| Normal-vs-Female |
5.585700E-02 |
| Male-vs-Female |
3.022200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.045300E-04 |
| Normal-vs-Extreme_Weight |
5.18770026936011E-10 |
| Normal-vs-Obese |
1.315590E-03 |
| Normal-vs-Extreme_Obese |
1.863330E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.695400E-01 |
| Normal_Weight-vs-Obese |
3.158000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.275200E-01 |
| Extreme_Weight-vs-Obese |
4.398700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.906400E-01 |
| Obese-vs-Extreme_Obese |
4.449200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.604460E-03 |
| Normal-vs-Age(41-60Yrs) |
7.54720000000209E-05 |
| Normal-vs-Age(61-80Yrs) |
4.58709999984208E-08 |
| Normal-vs-Age(81-100Yrs) |
4.02520000000184E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.479200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.383200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.469800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.017620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.313400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.019800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.27320000098408E-08 |
| Normal-VS-Type2 PRCC |
3.959000E-03 |
| Normal-VS-KIRP CIMP |
2.555800E-01 |
| Normal-VS-Unclassified PRCC |
4.071800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.418200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.747960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.930100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.792800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.730600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.175800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.04149999999803E-05 |
| Normal-vs-N1 |
4.603600E-03 |
| Normal-vs-N2 |
6.294600E-01 |
| N0-vs-N1 |
7.651600E-01 |
| N0-vs-N2 |
5.577000E-01 |
| N1-vs-N2 |
6.654000E-01 |
|
|
